Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

PubMed Links for Books (Select 1509774)

1.

Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.

Kawata K, Kanai M, Sasada T, Iwata S, Yamamoto N, Takabayashi A.

Clin Cancer Res. 2004 Jun 1;10(11):3788-93.

2.

99mTc-MIBI in the evaluation of breast cancer biology.

Del Vecchio S, Salvatore M.

Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S88-96. Epub 2004 Apr 23. Review.

PMID:
15105972
3.

Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines.

Aloj L, Zannetti A, Caracó C, Del Vecchio S, Salvatore M.

Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):521-7. Epub 2003 Dec 10.

PMID:
14666386
4.

Formulation and evaluation of a two-components lyophilized kit for Tc-sestamibi: transchelation preparation of Tc-99m-sestamibi.

Pandey PM, Sachdev SS, Ramamoorthy N, Lal R, Ranganatha DK, Narasimhan S, Oommen R, Gunasekaran S, Nair NA.

Nucl Med Biol. 1997 Oct;24(7):697-700. No abstract available.

PMID:
9352543
5.

Genetic analysis of the multidrug transporter.

Gottesman MM, Hrycyna CA, Schoenlein PV, Germann UA, Pastan I.

Annu Rev Genet. 1995;29:607-49. Review.

PMID:
8825488
6.

BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy.

Reed JC, Miyashita T, Takayama S, Wang HG, Sato T, Krajewski S, Aimé-Sempé C, Bodrug S, Kitada S, Hanada M.

J Cell Biochem. 1996 Jan;60(1):23-32. Review.

PMID:
8825412
7.

Membrane potential determination in large unilamellar vesicles with hexakis(2-methoxyisobutylisonitrile)technetium(I).

Chernoff DM, Strichartz GR, Piwnica-Worms D.

Biochim Biophys Acta. 1993 Apr 22;1147(2):262-6.

PMID:
8476920
8.

Biochemistry of multidrug resistance mediated by the multidrug transporter.

Gottesman MM, Pastan I.

Annu Rev Biochem. 1993;62:385-427. Review. No abstract available.

PMID:
8102521
9.
10.

Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.

Piwnica-Worms D, Rao VV, Kronauge JF, Croop JM.

Biochemistry. 1995 Sep 26;34(38):12210-20.

PMID:
7547962
11.

Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile.

Okada RD, Glover D, Gaffney T, Williams S.

Circulation. 1988 Feb;77(2):491-8.

PMID:
3338137
12.

Comparative myocardial uptake characteristics of hexakis (alkylisonitrile) technetium(I) complexes. Effect of lipophilicity.

Piwnica-Worms D, Kronauge JF, Holman BL, Davison A, Jones AG.

Invest Radiol. 1989 Jan;24(1):25-9.

PMID:
2917819
13.

Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, Boucher CA, Picard M, Holman BL, Fridrich R, et al.

J Nucl Med. 1989 Mar;30(3):301-11.

14.

Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells.

Piwnica-Worms D, Kronauge JF, Delmon L, Holman BL, Marsh JD, Jones AG.

J Nucl Med. 1990 Apr;31(4):464-72.

15.

Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro.

Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG.

Cancer Res. 1990 Apr 1;50(7):2198-202.

17.

Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts.

Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, Piwnica-Worms D.

J Nucl Med. 1992 Aug;33(8):1516-22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk